India, April 28 -- Marksans Pharma Ltd. wishes to inform that the USFDA has conducted a current Good Manufacturing Practices (cGMP) inspection at the manufacturing facility of its wholly owned subsidiary, Time-Cap Laboratories, Inc., located at 7 Michael Avenue, Farmingdale, New York, USA. The inspection took place from April 16, 2025, to April 24, 2025.
Following the conclusion of the inspection, the subsidiary received one observation in Form 483. Importantly, there were no data integrity-related observations. Time-Cap Laboratories, Inc. will work closely with the USFDA to address the observation comprehensively within the prescribed timeline.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....